High altitude, a natural research laboratory for the study of cardiovascular physiology and pathophysiology.
Détails
ID Serval
serval:BIB_18A747A55573
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
High altitude, a natural research laboratory for the study of cardiovascular physiology and pathophysiology.
Périodique
Progress in Cardiovascular Diseases
ISSN
1532-8643[electronic], 0033-0620[linking]
Statut éditorial
Publié
Date de publication
2010
Volume
52
Numéro
6
Pages
451-455
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Résumé
High altitude constitutes an exciting natural laboratory for medical research. Although initially, the aim of high-altitude research was to understand the adaption of the organism to hypoxia and find treatments for altitude-related diseases, during the past decade or so, the scope of this research has broadened considerably. Two important observations led the foundation for the broadening of the scientific scope of high-altitude research. First, high-altitude pulmonary edema represents a unique model that allows studying fundamental mechanisms of pulmonary hypertension and lung edema in humans. Second, the ambient hypoxia associated with high-altitude exposure facilitates the detection of pulmonary and systemic vascular dysfunction at an early stage. Here, we will review studies that, by capitalizing on these observations, have led to the description of novel mechanisms underpinning lung edema and pulmonary hypertension and to the first direct demonstration of fetal programming of vascular dysfunction in humans.
Mots-clé
Altitude, Altitude Sickness/complications, Altitude Sickness/drug therapy, Animals, Biomedical Research, Cardiovascular System/physiopathology, Clinical Trials as Topic, Dexamethasone/therapeutic use, Drug Therapy, Combination, Evidence-Based Medicine, Foramen Ovale, Patent/complications, Glucocorticoids/therapeutic use, Humans, Hypertension, Pulmonary/physiopathology, Nitric Oxide/biosynthesis, Oxidative Stress, Phosphodiesterase Inhibitors/therapeutic use, Pulmonary Edema/physiopathology, Risk Factors, Sympathetic Nervous System/physiopathology, Treatment Outcome, Vasodilator Agents/therapeutic use
Pubmed
Web of science
Création de la notice
26/05/2010 10:55
Dernière modification de la notice
20/08/2019 12:49